Practice question

Answer the question and get instant feedback.

Mediumeven without diabetes. DPP‑4 inhibitors (B)CKD G3b A3kdigo guideline (2024): evaluation and management of chronic kidney disease

A 63-year-old with CKD G3b A3 (eGFR 38 mg/g) without diabetes. BP is controlled on ACE inhibitor. Which additional agent is recommended to slow CKD progression?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.